JPRN-UMIN000025841
Recruiting
未知
Effects of sodium-glucose co-transporter2(SGLT2) inhibitors on left ventricular systolic and/or diastolic dysfunction in Japanese type2 diabetes - Effects of sodium-glucose co-transporter2(SGLT2)inhibitors on left ventricular dysfunction
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type2 diabetic patients with systolic and/or diastolic dysfunction
- Sponsor
- Kanagawa Cardiovascular and Respiratory Center
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1patients with type1 diabetes 2Patients with severe infection, perioperative, severe ketosis, severeinjury 3Patients with mild renal dysfunction(sCr\>1\.5mg/dl) 4Patients with severe heart failure(NYHA class 4\) 5Patients with serious hepatic dysfunction 6Patients with mild MR 7Patients with atrial fibrillation 8Patients with risk of dehydration 9Patients with malignancy 10Patients with malnutrition, stavation 11Patients who are pregnant, breastfeeding or may become pregnant 12Patients taking SGLT2I 13Patients who considered not eligible for the study by the attending doctor due to other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on biomarkers in early diabetic nephropathy in Japanese with type 2 diabetesJPRN-UMIN000021619Yokohama City University Graduate School of Medicine20
Completed
Phase 4
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2020/02/023195izams Institute of Medical Sciences
Completed
Not Applicable
Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on metabolic parameters in patients with type 2 diabetes: A chart-based analysistype 2 diabetesJPRN-UMIN000020314ational Center for Global Health and Medicine Kohnodai Hospital75
Terminated
Not Applicable
Effects of Sodium Glucose Co-Transpoter-2 (SGLT-2) in diabetics with heart failureHeart failureType 2 DiabetesCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - DiabetesACTRN12618000795291Endcrinology Department, Box Hill Hospital - Eastern Health2
Not yet recruiting
Not Applicable
The effects Of sodium-glucose coTransporter 2 inhibiTOR on fastIng Hepatic Insulin Clearance in type 2 diabetesJPRN-jRCT1061230070Okura Tsuyoshi20